Dermatology NewsTNF inhibitors may dampen COVID-19 severityMay 19, 2020COVID-19 UpdatesPsoriatic Arthritis
Dermatology NewsPsoriasis patients with mental illness report lower satisfaction with physiciansMay 15, 2020PsoriasisMixed TopicsPsoriatic Arthritis
Dermatology NewsAdvice on treating rheumatic diseases from a COVID-19 epicenterMay 13, 2020COVID-19 UpdatesPediatricsPsoriatic Arthritis
Dermatology NewsACR gives guidance on rheumatic disease management during pandemicMay 12, 2020COVID-19 UpdatesPsoriatic Arthritis
Dermatology NewsBiologics better solo than with methotrexate in psoriatic arthritisMay 1, 2020Psoriatic Arthritis
Dermatology NewsCase series suggests biologics, JAK inhibitors safe during pandemicMay 1, 2020Psoriatic ArthritisCOVID-19 UpdatesPsoriasis
Dermatology NewsLatest data on COVID-19 patients with rheumatic diseases revealed in registryApril 23, 2020COVID-19 UpdatesPediatricsPsoriasisPsoriatic Arthritis
Dermatology NewsFinancial incentives affect the adoption of biosimilarsApril 16, 2020Business of MedicinePsoriatic ArthritisPsoriasis
Dermatology News‘We’re in great distress here,’ infusion center CMO saysApril 10, 2020COVID-19 UpdatesPsoriatic ArthritisPsoriasis
Dermatology NewsJAK inhibitors may increase risk of herpes zosterApril 7, 2020Infectious DiseasesMixed TopicsPsoriatic ArthritisPsoriasis
Dermatology NewsGenome study examines heritability of psoriatic disease subtypesApril 2, 2020Psoriatic ArthritisPsoriasis
Dermatology NewsRapid shift to adalimumab biosimilars in Denmark contrasts with U.S. experienceMarch 31, 2020Psoriatic ArthritisPediatricsPsoriasis
Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics? March 23, 2020COVID-19 UpdatesPsoriasisInfectious DiseasesPsoriatic Arthritis
Dermatology NewsAAD-NPF releases first guidelines for nonbiologic treatments of psoriasisMarch 11, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsSecukinumab outperforms adalimumab overall for PsAFebruary 27, 2020Psoriatic Arthritis
